SHARDACROPChemicals

Sharda Cropchem Limited

Pesticides & Agrochemicals · ISIN INE221J01015 · BSE 538666 · NSE EQ · FV ₹10
Last price
₹742
-0.51%today
What this company does

Sharda Cropchem Limited operates in Pesticides & Agrochemicals, part of the Chemicals sector. It booked ₹1,074 cr of revenue in its latest quarter (Q1 FY27) and kept 8.2% of sales as profit. It is the 4th largest of 9 Pesticides & Agrochemicals companies we track, by market value.

Sharda Cropchem Israel Limited is engaged in the business of dealing in agrochemical products in Israel.
Sharda Italia SRL is engaged in the business of dealing in agrochemical products in Italy.
In the report:
60out of 100
Equitytale Health Score
Mixed

Healthier than 60% of companies in Chemicals, on all six measures of filed financials. Each measure is ranked against the 10–44 companies that reported it.

Measures financial condition, not whether to buy. Learn what this score means · How this is calculated

Price momentum
neutral
RSI (14)
34

At close. Not part of the score.

Profitability & returns35

How much profit it earns on the money it employs

Balance sheet87

How much it owes, and whether earnings cover the interest

Cash quality68

Whether reported profit actually arrives as cash

Growth & consistency78

Whether sales and profit have grown, and how steadily

Valuation11

What today's price implies, against our models or its peers

Governance & risk100

How much of the promoters' stake is pledged, and how much they hold · highest in its sector on what we could measure

Is this company doing well?
not investment advice
Strengths
Makes a profit
Sales up 9% vs last year
Promoters hold 75%
No promoter shares pledged
Virtually debt-free
Turns profit into real cash
Watch-outs
! Profit down 38% vs last year

What if I invest in SHARDACROP?

Set a growth rate and see what a monthly SIP would add up to. Your assumption, our arithmetic.

You would put in
₹12.00 lakh
120 instalments
At 15% a year, it would become
₹26.30 lakh

The slider starts at 15%, taken from this company's own free-cash-flow trend. That is history, not a forecast — this is your assumption, and the figure above is arithmetic on it. Returns are not steady year to year, and a real holding would not grow in a straight line. We do not publish price targets or predict returns.

Key ratios · latest quarter + price
₹742 -0.51%
latest close · 2026-09-17
1-year return
+141.0%
52-wk low ₹29652-wk high ₹893
Is it cheap or expensive?
What you pay for the profits, book value and cash flow. Higher isn't automatically worse — it can signal faster growth.
P/E ratio19.0Average
LowAverageHigh
P/B ratio2.13Moderate
Below bookModerateHigh
EV / EBITDA7.3Low
LowAverageHigh
How good is the business?
How much profit it earns from its money and its sales.
Return on equity11.2%Fair
WeakFairStrong ▸15%
Return on capital14.2%Fair
WeakFairStrong
Net margin8.2%Decent
ThinDecentStrong
EBITDA margin20.5%Healthy
ThinDecentHealthy
Is it financially safe?
How much it owes, and whether it can comfortably cover it.
Debt to equity0.00Comfortable
LowModerateHigh ▸1
Interest cover66.6×Strong
RiskyOkayStrong ▸5×
Current ratio1.86Healthy
Tight ◂1HealthyAmple
More figures
Market cap
₹6,692 cr
Book value
₹348
EPS
₹9.76
latest quarter
Net debt
₹-220 cr
more cash than debt
Enterprise value
₹6,472 cr
EBITDA
₹882 cr
annualised
EBIT
₹481 cr
annualised
Operating margin
11.2%
Return on assets
6.1%
Earnings yield
5.26%
P/S
1.56
Sales / share
₹476.1
Tax rate
25.7%
Face value
₹10
Shares
9.0 cr
Working capital
₹2,052 cr
Current assets
₹4,438 cr
Current liabilities
₹2,386 cr
Delivery %
54.2%
Strong / safeFairWeak / riskyValuation — a level, not good/badBands are general rules of thumb, not advice.

P/E, ROE, ROCE and margins are annualised from the latest quarter; per-share and balance-sheet ratios use the most recent balance sheet on file · prices as of 2026-09-17.

Worth vs price · from the FY 2026 report & filings
not investment advice
Looks overpricedMedium confidence
Median of 3 models ₹350 vs market price ₹742 — price is 112% above it
Safety cushion-112.0%(target ≥ +20%)
Models span ₹270₹655, midpoint ₹350
Model ₹350
Price ₹742
Cheap sideExpensive side

An educational model from the company's own filings, every assumption shown — not investment advice or a price target. Prices can stay above or below any model for years.

P&L · Q1 FY27 (consolidated)
Revenue from Operations₹1,074 cr
Other Income₹35 cr
Total Income₹1,108 cr
Cost of Materials₹374 cr
Purchases of Stock-in-Trade₹476 cr
Inventory Change (±)₹-170 cr
Employee Benefit Expense₹18 cr
Finance Costs₹2 cr
Depreciation & Amortisation₹100 cr
Other Expenses₹190 cr
Total Expenses₹990 cr
Profit before Tax₹118 cr
Tax Expense₹30 cr
Net Profit₹88 cr
Net margin on total income7.9%
Where the money goes · Q1 FY27
% of total income
Materials + stock-in-trade₹680 cr61.3%
Employee benefit expense₹18 cr1.6%
Finance costs₹2 cr0.2%
Depreciation & amortisation₹100 cr9.0%
Other expenses₹190 cr17.2%
Tax expense₹30 cr2.7%
Profit for the period₹88 cr7.9%
Total income ₹1,108 cradds up to ₹100 ✓
Quarterly results · consolidated (₹ cr)
MetricQ3 FY26Q4 FY26Q1 FY27
Revenue1,289 cr2,065 cr1,074 cr
Total income1,310 cr2,087 cr1,108 cr
Expenses1,131 cr1,665 cr990 cr
Profit before tax179 cr422 cr118 cr
Tax33 cr103 cr30 cr
Net profit (owners' share)145 cr319 cr88 cr
Net margin (owners' share, on revenue)11.3%15.4%8.2%
EPS (₹)16.0935.329.76
YoY (latest quarter): total income +8.9% · net profit -38.3%
Balance sheet & cash flow · as of Mar 2026
Debt-free
Total assets
₹5,780 cr
Shareholder equity
₹3,136 cr
parent shareholders
Total debt
₹0 cr
Cash
₹220 cr
Cash flow · H1 FY26
Operating
₹605 cr
Investing
₹-524 cr
Financing
₹-59 cr
Peer comparison
Pesticides & Agrochemicals · by market value
CompanyPriceMarket capP/E
UPL Limited₹555₹3.37 L cr1,155.7
PI Industries Limited₹2,307₹35,066 cr35.8
Sumitomo Chemical India Limited₹455₹22,734 cr26.5
Sharda Cropchem Limitedthis company₹742₹6,692 cr19.0
Dhanuka Agritech Limited₹982₹4,428 cr14.7
Rallis India Limited₹204₹3,971 cr
NACL Industries Limited₹149₹3,488 cr41.8
Bhagiradha Chemicals & Industries Limited₹248₹3,215 cr60.2
GSP Crop Science Limited₹484₹2,252 cr21.3
Same industry · latest reported numbers · not a recommendation.
Corporate actions
Dividend yield
2.02%
trailing 12 months
Dividend / share (TTM)
₹15
Last dividend
₹9
ex 7 Aug 2026
ActionDetailEx-date
Dividend₹9 / share7 Aug 2026
Dividend₹6 / share6 Feb 2026
Dividend₹6 / share7 Aug 2025
Dividend₹3 / share6 Feb 2025
Dividend₹3 / share2 Aug 2024
Dividend₹3 / share1 Aug 2023
Who owns it · 2026-06-30
No pledge
Promoter
74.8%
FII / Foreign
3.1%
DII / Domestic
9.2%
Retail / others
12.9%
Smart-money activity
Insider trades
SoldMrs. Sharda R. Bubna · Promoters1.00 L · ₹5.0 cr8 Feb 17
SoldMr. Ramprakash V. Bubna · Promoters1.00 L · ₹5.0 cr8 Feb 17
Bulk / block deals
short · NSE10026 Aug 26
short · NSE104 Aug 26
short · NSE8324 Jul 26
Stake changes
BoughtHDFC Asset Management Company Ltd→ 7.82% · 24.67 L20 Jul 18
SoldDSP BlackRock Trustee Company Pvt. Ltd. on behalf of schemes of DSP BlackRock Mutual Fund and DSP BlackRock Alternative Investment Fund (Seller)→ 4.92% · 7.17 L14 May 18
SoldDSP BlackRock Trustee Company Pvt Ltd on behalf of schemes of DSP BlackRock Mutual Fund and DSP Black Rock Alternative Investment Fund (Seller) · promoter→ 4.92% · 7.17 L14 May 18
What shareholders were asked to approve

A company cannot decide everything on its own. Things like a top executive’s pay, issuing new shares, or re-appointing a director have to be put to the people who own the company, and they vote — one vote per share. So whoever owns the most shares has the most say.

Yearly shareholder meeting · 14 Aug 2026
See the official result
1
To receive, consider and adopt the Audited Standalone Financial Statements of the Company for the financial year ended 31st March, 2026, together with the Reports of the Board of Directors and the Auditors thereon.
Backed by 100% of shareholders other than promotersneeded 50%
1.04 cr votes for, 209 against · 0% of mutual funds and other big investors said no
2
To receive, consider and adopt the Audited Consolidated Financial Statements of the Company for the financial year ended 31st March, 2026, together with the Report of the Auditors thereon.
Backed by 99% of shareholders other than promotersneeded 50%
1.04 cr votes for, 61,136 against · 1% of mutual funds and other big investors said no
3
To declare a Final dividend on Equity Shares of the Company for the Financial Year 2025-26.
Backed by 100% of shareholders other than promotersneeded 50%
1.04 cr votes for, 206 against · 0% of mutual funds and other big investors said no
4
To appoint a Director in place of Mr Ashish R. Bubna (DIN: 00945147), who retires by rotation and being eligible, offers himself for re-appointment
Promoters had a personal stake in this
Backed by 98% of shareholders other than promotersneeded 50%
1.02 cr votes for, 2.16 L against · 2% of mutual funds and other big investors said no

Every vote count above is taken from the result the company filed with the stock exchange, certified by an independent counter. To work out what would have happened without the promoters, we simply remove their votes and re-apply the same legal bar the proposal had to clear. Nothing here is an estimate or an opinion.

Who controls this company, and what it pays them

Most Indian companies are controlled by a family or group — the promoters. The exchange requires them to be listed by name, including members who own no shares at all, and requires the company to disclose any business it does with them.

The promoter group — 6 named members
owning 74.8% between them · as of 2026-06-30
ASHISH RAMPRAKASH BUBNA16.83%
MANISH RAMPRAKASH BUBNA16.83%
SHARDA RAMPRAKASH BUBNA15.62%
RAMPRAKASH VILASRAI BUBNA15.58%
ANISHA MANISH BUBNA4.99%
SEEMA ASHISH BUBNA4.99%

Names and holdings from the company’s shareholding pattern filed with the exchange; transactions from the related-party note in its annual report. Every figure is as filed — these are legal, disclosed dealings, and what to make of them is your call.

How the stock has moved · adjusted for splits & bonuses
Data from primary exchange filings · analysis tool, not investment advice.